Drug
MK0653A clinical trials
How studies write it
Studies that test it under each name
Name
- MK0653A, ezetimibe (+) simvastatin
- 3
Studies by the year they started
5 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses MK0653A is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)CompletedPhase 3Organon and CoNCT00092651Written as MK0653A, ezetimibe (+) simvastatin
- A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)CompletedPhase 3Organon and CoNCT00110435Written as MK0653A, ezetimibe (+) simvastatin
- Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)CompletedPhase 3Organon and CoNCT00090168Written as MK0653A , ezetimibe (+) simvastatin
- A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)CompletedPhase 3Organon and CoNCT00132717Written as MK0653A (ezetimibe [+] simvastatin)
- MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)CompletedPhase 3Organon and CoNCT00092690Written as MK0653A, ezetimibe (+) simvastatin